Study to Investigate Pregnancy Outcomes in Female Participants Exposed to Subcutaneous (SC) Peginterferon Beta-1a and Intramuscular (IM) Interferon Beta-1a Reported in a German Participant Support Program

CompletedOBSERVATIONAL

Enrollment

470

Participants

Timeline

Start Date

April 30, 2021

Primary Completion Date

October 15, 2021

Study Completion Date

October 15, 2021

Conditions

Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting

Interventions

DRUG

Interferon Beta Therapy

Administered as specified in the treatment arm.

Trial Locations (1)

Research Site, Göttingen